Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: A cohort study

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Sørensen, Rikke ^a   Abildstrom, Steen Z ^b,c   Weeke, Peter ^a   Fosbøl, Emil L ^a   Folke, Fredrik ^a   Hansen, Morten L ^a   Hansen, Peter R ^a   Madsen, Jan K ^a   Abildgaard, Ulrik ^a   Køber, Lars ^d   Poulsen, Henrik E ^d,e   Torp Pedersen, Christian ^a   Gislason, Gunnar H ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE; DRUG DERIVATIVE; TICLOPIDINE;

ARTICLE; BLEEDING; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; HAZARD RATIO; HEART INFARCTION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK ASSESSMENT; TREATMENT DURATION; AGED; COMPARATIVE STUDY; DENMARK; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649293340     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-6     Document Type: Article

References (24)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England journal of medicine 2001, 345(7):494-502. 10.1056/NEJMoa010746, 11519503.
2. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358(9281):527-33. 10.1016/S0140-6736(01)05701-4, 11520521.
3. Steinhubl SR, Berger PB, Mann JT, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 2002, 288(19):2411-20. 10.1001/jama.288.19.2411, 12435254.
4. Yusuf S, Mehta SR, Zhao F, Gersh BJ, Commerford PJ, Blumenthal M, et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003, 107(7):966-72. 10.1161/01.CIR.0000051362.96946.15, 12600908.
5. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. European heart journal 2007, 28(13):1598-660. 10.1093/eurheartj/ehm161, 17569677.
6. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. European heart journal 2005, 26(8):804-47. 10.1093/eurheartj/ehi138, 15769784.
7. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116(7):e148-304. 10.1161/CIRCULATIONAHA.107.181940, 17679616.
8. Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008, 299(5):532-9. 10.1001/jama.299.5.532, 18252883.
9. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 2006, 98(3):352-6. 10.1016/j.amjcard.2006.02.039, 16860022.
10. Sorensen R, Gislason GH, Fosbol EL, Rasmussen S, Kober L, Madsen JK, et al. Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study. Br J Clin Pharmacol 2008, 66(6):875-84. 10.1111/j.1365-2125.2008.03284.x, 2675763, 18823305.
11. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997, 44(4):445-8.
12. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003, 56(2):124-30. 10.1016/S0895-4356(02)00591-7, 12654406.
13. Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and validation of the Ontario acute myocardial infarction mortality prediction rules. Journal of the American College of Cardiology 2001, 37(4):992-7. 10.1016/S0735-1097(01)01109-3, 11263626.
14. Kumler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Kober L, et al. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008, 10(7):658-60. 10.1016/j.ejheart.2008.05.006, 18539522.
15. Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. European heart journal 2006, 27(10):1153-8. 10.1093/eurheartj/ehi705, 16399775.
16. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. Jama 2007, 297(2):159-68. 10.1001/jama.297.2.joc60179, 17148711.
17. De Luca G, Cassetti E, Marino P. Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials. J Thromb Thrombolysis 2009, 27(4):365-378. 10.1007/s11239-008-0223-0, 18498003.
18. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. The New England journal of medicine 2007, 356(10):1009-19. 10.1056/NEJMoa067722, 17296822.
19. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. Journal of the American College of Cardiology 2007, 50(5):463-70. 10.1016/j.jacc.2007.06.002, 17662400.
20. Mortensen J, Thygesen SS, Johnsen SP, Vinther PM, Kristensen SD, Refsgaard J. Incidence of bleeding in 'real-life' acute coronary syndrome patients treated with antithrombotic therapy. Cardiology 2008, 111(1):41-6. 10.1159/000113426, 18239391.
21. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine 2006, 354(16):1706-17. 10.1056/NEJMoa060989, 16531616.
22. Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 2006, 295(13):1531-8. 10.1001/jama.295.13.joc60034, 16533938.
23. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. Jama 2005, 294(10):1224-32. 10.1001/jama.294.10.1224, 16143698.
24. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. The New England journal of medicine 2003, 349(8):733-42. 10.1056/NEJMoa025142, 12930925.